Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hip fracture

WindNight / shutterstock.com

Why & How Our Biologic Drug Discussion with Patients Should Evolve

Paul H. Caldron, DO, PhD, MBA, & John R.P. Tesser, MD  |  February 17, 2019

As we turn the corner on the second decade of biologic use for rheumatic disorders, a reappraisal of approach in our communication with patients is due. In practice, the impact these agents have on patients’ lives justifies the friction rheumatologists face when connecting patients to them. You can understand why older rheumatologists who apprenticed on…

Filed under:Biologics/DMARDsResearch RheumRheumatoid ArthritisSpeak Out Rheum Tagged with:OpinionSpeak Out Rheumatology

A Balancing Act: Tips to Ensure Optimal Screening & Treatment for Osteoporosis

Carina Stanton  |  November 12, 2018

Patients with rheumatic diseases may be undertreated for osteoporosis. To decrease fracture risk for at-risk patients, rheumatologists can engage patients in shared decision making with regular screening and education about treatment options…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:bonefracture riskFracturesOsteoporosispatient care

Does the Metal-Fatigue Principle Apply to Elderly Bones?

Mary Beth Nierengarten  |  August 16, 2018

Can principles from engineering provide a broader understanding of how the human skeleton works and be used to help prevent a common and often consequential event for people as they age—bone fractures? Research from a team of investigators that includes orthopedic surgeons and mechanical engineers suggests that, yes, looking at how engineered materials, such as…

Filed under:Conditions Tagged with:bonebone breakbone remodelingFractures

Improve Your Recognition & Treatment of Osteoporosis

Jason Liebowitz, MD, FACR  |  July 19, 2018

BALTIMORE—Rheumatologists may not think about osteoporosis on a daily basis, but they should, said Dr. Karl Insogna, the Ensign Professor of Medicine at Yale University School of Medicine and director of the Yale Bone Center in New Haven, Conn., in his recent lecture at the Maryland Society for the Rheumatic Diseases. With approximately 75 million…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:alendronatebisphosphonatesCorticosteroidsdenosumabOsteoporosisraloxifenerisedronateteriparatidezoledronic acid

When Is It Appropriate to Discontinue Bisphosphonates?

Thomas R. Collins  |  June 21, 2018

CHICAGO—A 75-year-old woman with low bone density, who has had a fracture and has other risk factors for fracture, is treated with the bisphosphonate alendronate. After five years on the drug she comes back, wondering: Should I stop taking the drug? She’s had no additional fractures. Her bone density has improved, but her lumbar spine…

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:bisphosphonatesOsteoporosis

3 Experts Discuss Bone Health

Thomas R. Collins  |  February 18, 2018

SAN DIEGO—At the 2017 ACR/ARHP Annual Meeting Nov. 3–8, experts discussed improving bone health in the U.S., gave tips on bone health disorders in pediatrics and reviewed new translational science findings for joint conservation in early osteonecrosis. E. Michael Lewiecki, MD, director of the New Mexico Clinical Research & Osteoporosis Center in Albuquerque, N.M., called…

Filed under:Meeting ReportsOsteoarthritis and Bone Disorders Tagged with:ACR/ARHP Annual Meetingbone and jointJuvenile arthritisOsteoarthritisOsteonecrosis

Letter: Tips to Improve Osteoporosis Screening Rates

Timothy Harrington, MD  |  October 16, 2017

Osteoporosis Screening The aphorism, “Those who do not learn history are doomed to repeat it,” applies to The Rheumatologist August 2017 article that documents the continued low screening rates for those at high risk for osteoporosis-related fragility fractures, in particular people older than 65 and those who have suffered a fracture already. So here’s a…

Filed under:ConditionsOpinionOsteoarthritis and Bone DisordersSpeak Out Rheum Tagged with:Fracturesnurse coordinatorOsteoporosispatient carePractice Managementrheumatologistrheumatologyriskscreening

Poor Sleep Associated with Higher Risk of Chronic Pain

Carolyn Crist  |  September 20, 2017

(Reuters Health)—People who sleep poorly may be more likely to develop a chronic pain condition and have worse physical health, a study from the U.K. suggests. A general decline in both the quantity and quality of hours slept led to a two- to three-fold increase in pain problems over time, researchers found. “Sleep and pain…

Filed under:ConditionsPain Syndromes Tagged with:Chronic painhip painJoint PainPainSleepsleep disorder

Osteoporosis Screening Is Underutilized Despite Recommendations

Osteoporosis Screening Is Underutilized Despite Recommendations

Mary Beth Nierengarten  |  August 15, 2017

For years, guidelines from various organizations have recommended osteoporosis screening in women and men starting at a specific age or based on specific risk factors. Among these guidelines are those developed by the U.S. Preventive Services Task Force (USPSTF) that recommend universal osteoporosis screening for women 65 years of age and older and for targeted…

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:bone density testbone diseasebone massbone mineral density (BMD)Fractureship fractureOsteoporosispreventionResearchrheumatologistscreeningWomen

Genetic Analysis Provides Insights into How Human Growth Is Linked to OA

Lara C. Pullen, PhD  |  July 31, 2017

Research has shed light on the genetic mutations that link GDF5 with arthritis and height. An ancient regulatory variant in GROW1 has been repeatedly selected in humans in northern environments, explaining the high frequency of a GDF5 haplotype that increases arthritis susceptibility…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:bone growthgeneGenetic researchgeneticsgrowthOsteoarthritisosteoarthritis (OA)

  • « Previous Page
  • 1
  • …
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 27
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences